Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | Metafectene | publication | K. Nolan et al., Europ. J. of Neuroscience, 2016, 43: 640-652; doi:10.1111/ejn.13160 | |||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | stable transfection | Metafectene | publication | M. C. Hogg et al., Brain Commun., 2020, 1 of 17, doi:10.1093/braincomms/fcaa138 | Link | |
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | stable transfection | Metafectene | publication | K. M. Danzer et al., J. Neurosci., Aug 2007; 27: 9220 - 9232 | ||
SHEP-SF |
Human neuroblastoma cell line | Human | unknown | cell line | adherent | plasmid | Metafectene | publication | T. Müller et al., Mol. Biol. Cell, Jan 2007; 18: 201 - 210 | Link | |||
SK-MEL-3 |
Human skin malignant metastatic melanoma cell line | ATCC HTB-69 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Pigment Cell Melanoma Res., 2013, 26: 900–911, doi: 10.1111/pcmr.12144 | ||
SK-N-BE(2) |
Human neuroblastoma cell line | ATCC CRL-2271 | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. Bertoni et al., J. Biol. Chem., 2011, 286 (6): 4727–4741, DOI 10.1074/jbc.M110.156521 | Link | |
SK-N-SH |
Human neuroblastoma cell line | ATCC HTB-11 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | Z. Ping et al., Cell Cycle, 2012, 11: 10, 1999-2005, doi.org/10.4161/cc.20402 | Link | |
SKBR3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | oligonucleotide | Metafectene | publication | C. Cava et al., Theranostics, 2020, 10(1): 50-61, doi: 10.7150/thno.36274 | Link | ||
SkBr3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | N. Golkar et al., Int. J. of Pharmaceutics, 2016, 510: 30-41; doi.org/10.1016/j.ijpharm.2016.06.026 | ||
SkBr3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | iron oxide | Metafectene | publication | L. Matuszewski et al., Radiology, Apr 2005; 235: 155 - 161 | |||
SkBr3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | N. Golkar et al., Data in Brief, 2016, 8:1018-1023; doi.org/10.1016/j.dib.2016.06.064 | Link | |
SKBR3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | oligonucleotide | Metafectene | publication | A. M. Tamaddona et al., Iranian J. of Pharm. Sci., 2011, 11: 7(2): 79-87 | Link | ||
SkBr3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | oligonucleotide | Metafectene | publication | C. Cava et al., Theranostics, 2020, 10(1): 50-61. doi: 10.7150/thno.36274 | Link | ||
SkBr3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene | publication | O. Gires et al., Anticancer Res, Nov 2004; 24: 3715 - 3722 | Link | |
SKMEL-224 |
Human skin malignant melanoma cell line | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene | publication | A. Renziehausen et al., Oncogene, 2019, 38:2320–2336, doi.org/10.1038/s41388-018-0563-y | |||
SKMEL-224 |
Human skin malignant melanoma cell line | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. Renziehausen et al., Oncogene, 2019, 38:2320–2336, doi.org/10.1038/s41388-018-0563-y | |||
SKMEL-23 |
Human skin malignant metastatic melanoma cell line | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene | publication | A. Renziehausen et al., Oncogene, 2019, 38:2320–2336, doi.org/10.1038/s41388-018-0563-y | |||
SKMEL-23 |
Human skin malignant metastatic melanoma cell line | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. Renziehausen et al., Oncogene, 2019, 38:2320–2336, doi.org/10.1038/s41388-018-0563-y | |||
SKMEL-28 |
Human skin malignant melanoma cell line | ATCC HTB-72 | Human | skin | cell line | adherent | plasmid | Metafectene | publication | D. Kobelt et al., Mol. Biotechnol., Mol Biotechnol, 2013, 53:80-89 | |||
SKMEL-28 |
Human skin malignant melanoma cell line | ATCC HTB 72 | Human | skin | cell line | adherent | minicircle | Metafectene | publication | D. Kobelt, Dissertation, 2012, Humboldt-Universität zu Berlin | Link | ||
SKMEL-28 |
Human skin malignant melanoma cell line | ATCC HTB 72 | Human | skin | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
SKMEL-28 |
Human skin malignant melanoma cell line | ATCC HTB 72 | Human | skin | cell line | adherent | MIDGE | Metafectene | publication | D. Kobelt, Dissertation, 2012, Humboldt-Universität zu Berlin | Link | ||
SKMEL-28 |
Human skin malignant melanoma cell line | ATCC HTB-72 | Human | skin | cell line | adherent | minicircle | Metafectene | publication | D. Kobelt et al., Mol. Biotechnol., Mol Biotechnol, 2013, 53:80-89 | |||
SKMEL-28 |
Human skin malignant melanoma cell line | ATCC HTB 72 | Human | skin | cell line | adherent | plasmid | Metafectene | publication | D. Kobelt, Dissertation, 2012, Humboldt-Universität zu Berlin | Link |